HTLV-I antibody studies in villagers in East Sepik Province, Papua New Guinea
- PMID: 2222189
- DOI: 10.1007/BF01311009
HTLV-I antibody studies in villagers in East Sepik Province, Papua New Guinea
Abstract
Serum samples collected in 1984 during a malariometric survey of two villages in the East Sepik Province of Papua New Guinea were tested for antibodies to HTLV-I. None of the villagers showed any symptoms suggestive of retrovirus infection. Eighteen of the 186 (9.5%) sera tested at that time were found to be positive. Blood samples were subsequently obtained from fifteen of the eighteen positives and subjected to analysis by enzyme-linked immunosorbent assay (ELISA), radioimmuno assay (RIA), radioimmunoprecipitation assay (RIPA), and Western blot (WB). Fourteen of the fifteen gave a positive ELISA response, but none were unequivocally positive by p 24 RIA. All sera tested were reactive to gag antigens by WB, but gave "indeterminate" results currently accepted criteria. Notably absent from the WB profiles of all of the study subjects was an antibody response to HTLV-I envelope protein gp 46. It is possible that these antibody responses are directed against a variant of HTLV-I or to a novel retrovirus which possesses core antigens similar to those of HTLV-I but has different envelope antigens. Until a virus is isolated, or the viral genome is identified in infected lymphocytes, the possibility remains that the response may be due to factors unrelated to retrovirus infection.
Similar articles
-
The prevalence of antibodies to human T-lymphotropic virus type I in different population groups in Papua New Guinea.Arch Virol. 1993;130(3-4):327-34. doi: 10.1007/BF01309664. Arch Virol. 1993. PMID: 8517792
-
Confirmatory tests for human T-cell leukemia virus type 1 (HTLV-1): western blot compared with RIPA on African sera.J Virol Methods. 1990 Dec;30(3):283-9. doi: 10.1016/0166-0934(90)90070-v. J Virol Methods. 1990. PMID: 2086599
-
Human T cell leukemia virus (HTLV-I/II) serodiagnostic testing: disparate results among a cohort of intravenous drug users.AIDS Res Hum Retroviruses. 1993 Oct;9(10):1043-50. doi: 10.1089/aid.1993.9.1043. AIDS Res Hum Retroviruses. 1993. PMID: 7904169 Clinical Trial.
-
HTLV-I antibody study in normal individuals and unselected hospital patients in Malaysia.Southeast Asian J Trop Med Public Health. 1992 Mar;23(1):26-9. Southeast Asian J Trop Med Public Health. 1992. PMID: 1355930
-
Human T-cell leukemia virus type-I/II (HTLV-I/II) serologic testing: the importance of assaying for the full complement of viral antigens.Viral Immunol. 1992 Summer;5(2):105-11. doi: 10.1089/vim.1992.5.105. Viral Immunol. 1992. PMID: 1616582
Cited by
-
Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.J Clin Microbiol. 2000 Nov;38(11):4049-57. doi: 10.1128/JCM.38.11.4049-4057.2000. J Clin Microbiol. 2000. PMID: 11060067 Free PMC article.
-
The prevalence of antibodies to human T-lymphotropic virus type I in different population groups in Papua New Guinea.Arch Virol. 1993;130(3-4):327-34. doi: 10.1007/BF01309664. Arch Virol. 1993. PMID: 8517792
-
Verification of HTLV-I infection in the Solomon Islands by virus isolation and gene amplification.Jpn J Cancer Res. 1991 Mar;82(3):240-4. doi: 10.1111/j.1349-7006.1991.tb01835.x. Jpn J Cancer Res. 1991. PMID: 1902446 Free PMC article.
-
Characterization of a variant of human T-lymphotropic virus type I isolated from a healthy member of a remote, recently contacted group in Papua New Guinea.Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1446-50. doi: 10.1073/pnas.88.4.1446. Proc Natl Acad Sci U S A. 1991. PMID: 1996344 Free PMC article.